What is Clinomic?
Founded in 2019, Clinomic has evolved from a specialized software developer into a comprehensive digital health group. The company's flagship solution, Mona, serves as a centralized hub for critical care, effectively bridging the gap between raw clinical data and actionable medical insights. Through its expansion into the Clinomic Group, the firm now addresses the broader spectrum of hospital digital transformation, including telemedicine and advanced data analytics. This multi-faceted approach allows Clinomic to optimize hospital workflows while simultaneously improving patient outcomes in high-acuity environments, a sector historically resistant to rapid technological adoption.
How much funding has Clinomic raised?
Clinomic has raised a total of $25.6M across 1 funding round:
Series B
$25.6M
Series B (2025): $25.6M with participation from DeepTech & Climate Fonds
Key Investors in Clinomic
DeepTech & Climate Fonds
DeepTech & Climate Fonds is a prominent venture capital entity managing 1 billion EUR, dedicated to supporting early growth ventures that develop transformative technologies within the German and European markets.
What's next for Clinomic?
With this major enterprise-level funding, Clinomic is poised to accelerate its international scaling efforts and deepen its R&D capabilities in predictive clinical analytics. The strategic focus will likely shift toward expanding the footprint of the Clinomic Group across European hospital networks, leveraging the recent capital to enhance the interoperability of the Mona platform. As the company matures, the emphasis will remain on navigating the complex regulatory requirements of the MedTech sector while maintaining its competitive edge in AI-assisted critical care. Future growth will be defined by the firm's ability to integrate its digital transformation services into existing hospital infrastructures, thereby cementing its role as an indispensable partner in modern healthcare delivery.
See full Clinomic company page